Regarding IFN-β, sustained signaling has been implicated in acquired immunotherapy resistance by inducing PD-L1 and NOS2 expression in both tumor and dendritic cells, leading to the accumulation of regulatory T cells (Tregs) and myeloid cells and resulting in acquired resistance to ICB.41 The gene discussed is IFNB1; the disease is neoplasm.